Constellation Pharmaceuticals' IPO

Constellation Pharmaceuticals raised a round of funding on July 19, 2018. Investors include Public.

Constellation Pharmaceuticals (NASDAQ: CNST) is a biopharmaceutical company dedicated to the development of therapeutics in the emerging field of Epigenetics, a new field of science involving selectiv…

Articles about Constellation Pharmaceuticals' IPO: